Instrument Inactif

Gouvernance Teva Pharmaceutical Industries Limited Other OTC

TEVJF

IL0006290147

Produits pharmaceutiques

Comité Exécutif: Teva Pharmaceutical Industries Limited

Dirigeant

Fonctions occupéesDepuis

Richard Francis

57 ans

Chief Executive Officer	01/01/2023
President	01/01/2023

Brian Savage

41 ans

General Counsel

01/02/2026

Christopher J. Stevo

Investor Relations Contact

Placid Jover Goma

45 ans

Human Resources Officer

01/08/2024

Matthew Shields

52 ans

Chief Operating Officer

03/06/2024

Kathleen Veit

Compliance Officer

01/07/2022

Eric Hughes

56 ans

Chief Tech/Sci/R&D Officer

01/08/2022

Amir Weiss

49 ans

Comptroller/Controller/Auditor

Dov Bergwerk

Corporate Secretary

01/10/2023

Eli Kalif

53 ans

Director of Finance/CFO

22/12/2019

Nir Baron

Comptroller/Controller/Auditor

01/05/2014

Composition du Conseil d'Administration: Teva Pharmaceutical Industries Limited

Administrateur

ComitésDepuis

Sol Barer

78 ans

Chairman	06/02/2017
Independent Dir/Board Member	01/01/2015

Gerald Lieberman

78 ans

Finance Committee	01/09/2015
Compensation Committee	01/09/2015
HR Committee	01/09/2015
Audit Committee Chair	01/09/2015

Roberto Mignone

54 ans

Finance Committee
Nominating Committee
Audit Committee	21/10/2024
Finance Committee Chair

Amir Elstein

69 ans

Audit Committee	01/01/2009
Finance Committee	01/01/2009
Governance Committee Chair	01/01/2009
Nominating Committee Chair	01/01/2009

Rosemary Crane

65 ans

Compensation Committee Chair	01/09/2015
HR Committee Chair

Perry Nisen

70 ans

Compensation Committee	14/07/2017
HR Committee	14/07/2017

Ronit Satchi-Fainaro

54 ans

Governance Committee	01/06/2018
Nominating Committee	01/06/2018

Chen Lichtenstein

58 ans

Audit Committee	01/12/2024
Finance Committee	01/12/2024

Tal Zaks

60 ans

Finance Committee

01/10/2021

Richard Francis

57 ans

Director/Board Member

01/01/2023

Anciens Dirigeants et Administrateurs: Teva Pharmaceutical Industries Limited

Insider

Fonctions occupées

DepuisJusqu'au

Kevin Mannix

Investor Relations Contact

01/05/2003

01/12/2021

Michael Hayden

Chief Tech/Sci/R&D Officer

01/09/2012

31/12/2017

Eyal Desheh

Chief Executive Officer	30/10/2013	12/02/2014
Director of Finance/CFO	12/02/2014	30/06/2017
President	01/07/2008	12/02/2014
Corporate Officer/Principal	01/01/1989	01/01/1996

Erez Vigodman

Director/Board Member	18/03/2010	06/02/2017
Chief Executive Officer	11/02/2014	06/02/2017
President	11/02/2014	06/02/2017

Roger Abravanel

Director/Board Member	01/01/2007	01/01/2017
Independent Dir/Board Member	01/01/2007	01/01/2017

Richard S. Egosi

General Counsel	18/03/2010	08/11/2016
Portfolio Manager-Equities	18/03/2010	18/03/2010
Corporate Secretary	18/03/2010	-

Itzhak Krinsky

Corporate Officer/Principal

01/10/2012

01/04/2016

Richard Alan Lerner

Director/Board Member

01/02/2012

01/09/2015

Phillip Frost

Director/Board Member	31/12/2014	04/02/2015
Chairman	10/03/2010	31/12/2014

Chaim Hurvitz

Director/Board Member	01/10/2010	01/07/2014
Corporate Officer/Principal	01/01/1999	01/10/2010

Dafna Schwartz

Director/Board Member	07/12/2011	30/06/2014
Independent Dir/Board Member	07/12/2011	30/06/2014

Ron Grupel

Comptroller/Controller/Auditor

18/03/2010

31/05/2014

Isaac Abravanel

Human Resources Officer	18/03/2010	02/09/2013
Corporate Officer/Principal	02/09/2013	06/03/2014

Frances M. Zipp

Corporate Officer/Principal

21/09/2011

01/02/2014

Roger Kornberg

Director/Board Member

18/03/2010

01/01/2013

Abraham E. Cohen

Director/Board Member

01/01/1992

22/11/2012

Shlomo Yanai

Chief Executive Officer	01/10/2006	01/06/2012
President	01/10/2006	01/06/2012

J. Buchi

Corporate Officer/Principal

01/10/2011

01/05/2012

Dan Propper

Director/Board Member

05/03/2012

Ruth Cheshin

Director/Board Member

01/01/1989

01/01/2012

Moshe Manor

Corporate Officer/Principal

27/09/2011

01/01/2012

Yitzhak Peterburg

Director/Board Member	01/11/2017	-
Chief Executive Officer	07/02/2017	12/09/2017
Chairman	01/01/2015	06/02/2017
Independent Dir/Board Member	01/01/2012	06/02/2017
Corporate Officer/Principal	01/01/2012	19/07/2013
President	06/02/2017	12/09/2017
Director/Board Member	01/01/2009	01/07/2010

Leora Meridor

Director/Board Member	01/01/2002	07/12/2011
Independent Dir/Board Member	19/09/2011	07/12/2011

Aharon Schwartz

Corporate Officer/Principal

01/01/1975

01/01/2011

Rivka Carmi

Director/Board Member

06/11/2009

06/04/2010

Eliyahu Hurvitz

Chairman	09/03/2010	09/03/2010
President	-	09/03/2010

Yossi Koren

Public Communications Contact

19/03/2010

Elon Kohlberg

Director/Board Member

18/03/2010

Harold Snyder

Director/Board Member

01/01/1996

18/12/2008

Gabriela Shalev

Director/Board Member

26/06/2008

Ory Slonim

Director/Board Member	18/03/2010	-
Independent Dir/Board Member	19/09/2011	-

Mitchell Shirvan

Corporate Officer/Principal

01/01/1992

01/01/2008

Joseph Nitzani

Director/Board Member	18/03/2010	-
Independent Dir/Board Member	19/09/2011	-

George Barrett

Corporate Officer/Principal

01/01/2005

01/01/2008

Israel Makov

Chief Executive Officer	01/04/2002	01/03/2007
President	01/04/2002	01/01/2007

Leslie Lewis Dan

Director/Board Member

01/01/2001

01/01/2007

Anat Mogilevsky

Human Resources Officer

01/05/2001

Max Reis

Director/Board Member

01/01/2001

Orna Balderman

Corporate Officer/Principal

01/01/1995

Moshe Many

Director/Board Member

01/01/1987

Ehud Geller

Corporate Officer/Principal

01/01/1979

01/01/1985

Aharon Yaari

Corporate Officer/Principal

21/09/2011

Daniel Zurr

Chief Executive Officer

01/01/1972

01/01/1980

Ben-Zion Weiner

Chief Tech/Sci/R&D Officer

19/03/2010

Uzi Karniel

Corporate Officer/Principal	22/09/2011	01/05/2012
Corporate Secretary	22/09/2011	-

Yoram Sela

Corporate Officer/Principal

Shir Altay Hagoel

Public Communications Contact

22/09/2011

Danny Levy

Corporate Officer/Principal

Yossi Ben-Harosh

Corporate Officer/Principal

Uri Danon

Corporate Officer/Principal

Jerry I. Treppel

Corporate Officer/Principal

Ezra Ouziel

Corporate Officer/Principal

Joseph Marczely

Public Communications Contact

Tomer Amitai

Public Communications Contact

Smadar Nestor

General Counsel

23/07/2009

Nir Nimrodi

Director of Finance/CFO	-	-
Corporate Officer/Principal	-	-

Anat Eitan

Corporate Officer/Principal

David A. Snyder

Corporate Officer/Principal

Amir Tirosh

Corporate Officer/Principal

Freddy Shaviv

Corporate Officer/Principal

David Shamir

Director/Board Member

Miri Ben-Ami

Corporate Officer/Principal

18/08/2011

Rodney Kasan

Corporate Officer/Principal

Harry Leinwand

Public Communications Contact	-	01/04/2010
General Counsel	01/04/2010	-

Yafit Stark

Chief Tech/Sci/R&D Officer

Liraz Kalif

Investor Relations Contact	14/09/2011	-
Public Communications Contact	-	-

Michael Sela

Director/Board Member

Yael Kenan

Corporate Officer/Principal

Suzanne M. Sensabaugh

General Counsel

Yisrael Dancziger

Corporate Officer/Principal

Asher Zysman

Director of Finance/CFO

Elana Holzman

Investor Relations Contact	03/05/2011	01/05/2012
Public Communications Contact	18/03/2010	-

Dov Shafir

Director/Board Member

01/01/1969

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	26
Femme	5

Dont comité exécutif

Homme	10
Femme	1

Dont Administrateurs

Homme	9
Femme	1

Révisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Non

Controverses sur les droits de l'Homme

Non

Controverses Subventions fiscales

Non

Conforme à la finance Islamique

Non

Teva Pharmaceutical Industries Ltd est une société pharmaceutique basée en Israël. La société opère à travers trois segments : Amérique du Nord, Europe et Marchés internationaux. Chaque secteur d'activité gère l'ensemble du portefeuille de produits dans sa région, y compris les médicaments génériques, les spécialités et les produits en vente libre. En plus de ces trois secteurs, la société a d'autres activités, principalement la vente d'ingrédients pharmaceutiques actifs (API) à des tiers, certains services de fabrication en sous-traitance et une plateforme de concession de licences offrant un portefeuille de produits à d'autres sociétés pharmaceutiques par l'intermédiaire de sa société affiliée Medis.

Employés

Secteur

Produits pharmaceutiques

Agenda

03/11 Publication des résultats - Q3 2026

Plus d'informations sur la société